Transaction · 0001415889-25-007467

Moshkevich Solomon

Moshkevich Solomon, PRES, reported an open-market or private sale at Natera, Inc. involving 1700.000000 shares for an estimated $245008.93. Reported holdings after the transaction were 144168.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SPRES
NTRANatera, Inc.
Filing timeMar 08
Trade dateMar 05, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

NTRA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
NTRA since 2025-03-08Filed 545 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001415889-25-007467
Common Stock
Transaction date
Mar 05, 2025
Filed Mar 08, 2025, 02:35 AM · 3d delay
Shares
1.70k sh
$14.4k per share
Estimated value
-$24.5M
Computed from shares × price
Holdings after
144k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

PRESIDENT, CLINICALDIAGNOSTICS

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024.

  2. F2

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.57 to $142.52 per share, inclusive. The holder undertakes to pro…

  3. F3

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.58 to $143.39 per share, inclusive. The holder undertakes to pro…

  4. F4

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.68 to $144.66 per share, inclusive. The holder undertakes to pro…

  5. F5

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.74 to $145.41 per share, inclusive. The holder undertakes to pro…

Original filing · 0001415889-25-007467
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

NTRA